Free Research Report on ABIOMED, Inc., Acco Brands Corp., Acorda Therapeutics, Inc., Addus HomeCare Corp and First Majestic

Free Research Report on ABIOMED, Inc., Acco Brands Corp., Acorda Therapeutics,
          Inc., Addus HomeCare Corp and First Majestic Silver Corp.

PR Newswire

NEW YORK, January 31, 2013

NEW YORK, January 31, 2013 /PRNewswire/ --

Today, Traders Insight announced new research reports highlighting ABIOMED,
Inc. (Nasdaq: ABMD), Acco Brands Corp. (NYSE: ACCO), Acorda Therapeutics, Inc.
(Nasdaq: ACOR), Addus HomeCare Corp (Nasdaq: ADUS) and First Majestic Silver
Corp. (NYSE: AG). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.

ABIOMED, Inc. Research Report
ABIOMED, Inc. develops temporary and permanent cardiac support systems. The
Company develops, manufactures and markets medical technologies designed to
assist or replace the pumping function of the failing heart. It focuses on the
development of two temporary support systems, the bi-ventricular support
system (BVS) and the intra-arterial cardiac support system (ICs). The Full
Research Report on ABIOMED, Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-30/2439_ABMD]

Acco Brands Corp. Research Report
ACCO Brands Corporation is a supplier of office products to the office
products resale industry. The Company designs, develops, manufactures and
markets a variety of traditional and computer-related office products,
supplies, binding and laminating equipment and related consumable supplies,
personal computer accessory products, paper-based time management products and
presentation aids and products. The Full Research Report on Acco Brands Corp.
- including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-30/ad82_ACCO]

Acorda Therapeutics, Inc. Research Report
Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical
company. The Company is engaged in the identification, development and
commercialization of novel therapies that improve neurological function in
people with multiple sclerosis (MS), spinal cord injury (SCI), and other
disorders of the nervous system. Ampyra (dalfampridine) is an extended release
tablet formulation of dalfampridine (4-aminopyridine, 4-AP). The Full Research
Report on Acorda Therapeutics, Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at: [http://www.TradersInsight.net/r/2013-01-30/fe67_ACOR]

Addus HomeCare Corp Research Report
Addus HomeCare Corporation is a provider of a range of social and medical
services in the home focused primarily on the dual eligible population. The
Company operates in two segments: home & community services and home health
services. The Company's services include personal care and assistance with
activities of daily living, skilled nursing and rehabilitative therapies, and
adult day care. The Full Research Report on Addus HomeCare Corp - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.TradersInsight.net/r/2013-01-30/9261_ADUS]

First Majestic Silver Corp. Research Report
First Majestic Silver Corp. (First Majestic), is engaged in the business of
silver production, development, exploration, and acquisition of mineral
properties with a focus on silver production in Mexico. The Company has three
operating segments located in Mexico, two development projects in Mexico, one
retail market segment in Canada and one silver trading segment in Europe. The
Full Research Report on First Majestic Silver Corp. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at: [http://www.TradersInsight.net/r/2013-01-30/2ab7_AG]

About Traders Insight
Our model of enabling open collaboration between members is breaking new
ground into the investment community. By tapping into the resources of the
community, we are crowd-sourcing our reach. As a result -- we have been able
to identify some of the greatest moving companies on the market today. The
evidence is in the results, join today and experience what you've been
missing.

Press Contact:

Cora S. Patton
press@TradersInsight.net
+1-203-297-6092 (North America)

SOURCE Traders Insight
 
Press spacebar to pause and continue. Press esc to stop.